Condition
Delayed Platelet Engraftment clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Delayed Platelet Engraftment clinical trials that are recruiting, in China. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Romiplostim to speed platelet recovery after haploidentical stem cell transplant
This trial will test whether weekly romiplostim helps adults with AML, MDS, or other blood cancers recover platelets faster after a haploidentical stem cell transplant.
-
Hetrombopag for improving platelet recovery in children with neuroblastoma after stem cell transplant
This study is testing if a new medication called hetrombopag can help children with neuroblastoma recover their platelet levels faster after a stem cell transplant.
Related topics
Quick answers
How many Delayed Platelet Engraftment clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.